Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0007. Premier Biomedical shares last traded at $0.0006, with a volume of 1,222,900 shares traded.
Premier Biomedical Stock Down 14.3%
Premier Biomedical Company Profile
Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.
Recommended Stories
- Five stocks we like better than Premier Biomedical
- What Are Treasury Bonds?
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Overbought Stocks Explained: Should You Trade Them?
- Amazon Is One of the Clearest Buys If the Market Dips Again
- How to Use High Beta Stocks to Maximize Your Investing Profits
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
